Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Mechanisms of T cell-mediated cytotoxicity remain poorly defined at the molecular level. To investigate some of these mechanisms, we used as target cells, on the one hand, thymocytes from lpr and gld mouse mutants, and on the other hand, L1210 cells transfected or not with the apoptosis-inducing Fas molecule. These independent mutant or transfectant-based approaches both led to the conclusion that Fas was involved in the Ca(2+)-independent component of cytotoxicity mediated by at least two sources of T cells, namely nonantigen-specific in vitro activated hybridoma cells, and antigen-specific in vivo raised peritoneal exudate lymphocytes. Thus, in these cases, T cell-mediated cytotoxicity involved transduction via Fas of the target cell death signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Yonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,400
Kriegler, M., Perez, C., DeFay, K., Albert, I., & Lu, S. D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,102
Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., & Trauth, B. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50076-x · Cited by 834
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1274 · Cited by 815
Owen-Schaub, L. B., Yonehara, S., Crump, W. L., & Grimm, E. A. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90187-t · Cited by 372
Cited by
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Self-citationMartin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., & Green, D. R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1545 · Cited by 2,824
Suda, T., Takahashi, T., Golstein, P., & Nagata, S. (1993) · Cell · doi:10.1016/0092-8674(93)90326-l · Cited by 2,489
Self-citationDeath and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,609
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Self-citationBrunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994) · Nature · doi:10.1038/370650a0 · Cited by 1,051
Fas ligand mediates activation-induced cell death in human T lymphocytes.
Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., & Lynch, D. H. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.71 · Cited by 934
Cytotoxic T lymphocytes: all roads lead to death
Barry, M., & Bleackley, R. C. (2002) · Nature Reviews Immunology · doi:10.1038/nri819 · Cited by 933
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
Molecular regulation of apoptosis: Genetic controls on cell death
Williams, G. T., & Smith, C. A. (1993) · Cell · doi:10.1016/0092-8674(93)90457-2 · Cited by 895
Fas and Fas ligand: lpr and gld mutations
Nagata, S., & Suda, T. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80069-7 · Cited by 892
Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H., & Ley, T. J. (1994) · Cell · doi:10.1016/0092-8674(94)90376-x · Cited by 812
Wild-Type Human p53 and a Temperature-Sensitive Mutant Induce Fas/APO-1 Expression
Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., et al. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3032 · Cited by 734
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1223 · Cited by 692
Downregulation of Fas ligand by shedding
Tanaka, M., Itai, T., Adachi, M., & Nagata, S. (1998) · Nature Medicine · doi:10.1038/nm0198-031 · Cited by 669
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka, M., Suda, T., Takahashi, T., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07096.x · Cited by 638
Kägi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., & Hengartner, H. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.207 · Cited by 588
Fas and FasL in the homeostatic regulation of immune responses
Lynch, D. H., Ramsdell, F., & Alderson, M. R. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80079-4 · Cited by 558
Liles, W. C., Kiener, P. A., Ledbetter, J. A., Aruffo, A., & Klebanoff, S. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.429 · Cited by 557
Fas transduces activation signals in normal human T lymphocytes.
Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F., & Lynch, D. H. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2231 · Cited by 521
The Fas System Is a Key Regulator of Germ Cell Apoptosis in the Testis*
Lee, J., Richburg, J. H., Younkin, S. C., & Boekelheide, K. (1997) · Endocrinology · doi:10.1210/endo.138.5.5110 · Cited by 519
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Berke, G. (1995) · Cell · doi:10.1016/0092-8674(95)90365-8 · Cited by 501
Wyllie, A. H. (1997) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011623 · Cited by 497
The Role of Fas in Autoimmune Diabetes
Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., & Matis, L. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80178-6 · Cited by 496
Ruefli, A. A., Ausserlechner, M. J., Bernhard, D., Sutton, V. R., Tainton, K. M., Kofler, R., Smyth, M. J., & Johnstone, R. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191208598 · Cited by 488
Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J.-L., & Elkon, K. B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352204 · Cited by 480
Essential roles of the Fas ligand in the development of hepatitis
Kondo, T., Suda, T., Fukuyama, H., Adachi, M., & Nagata, S. (1997) · Nature Medicine · doi:10.1038/nm0497-409 · Cited by 479
Maciejewski, J., Selleri, C., Anderson, S., & Young, N. (1995) · Blood · doi:10.1182/blood.v85.11.3183.bloodjournal85113183 · Cited by 476
Immune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Immune function in mice lacking the perforin gene.
Walsh, C. M., Matloubian, M., Liu, C. C., Ueda, R., Kurahara, C. G., Christensen, J. L., Huang, M. T., Young, J. D., Ahmed, R., & Clark, W. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10854 · Cited by 459
Development and Selection of T Cells: Facts and Puzzles
Kisielow, P., & Von Boehmer, H. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60620-3 · Cited by 444
Hyperproliferation and Dysregulation ofIL-4 Expression in NF-ATp-Deficient Mice
Hodge, M. R., Ranger, A. M., de la Brousse, F. C., Hoey, T., Grusby, M. J., & Glimcher, L. H. (1996) · Immunity · doi:10.1016/s1074-7613(00)80253-8 · Cited by 444
Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells
Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/374163a0 · Cited by 413
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishloka, W., Brunner, T., Baier, G., Baler-Bltterlich, G., Byrd, C., Lang, F., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90142-6 · Cited by 399
How do cytotoxic lymphocytes kill their targets?
Shresta, S., Pham, C. T., Thomas, D. A., Graubert, T. A., & Ley, T. J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80227-6 · Cited by 391
Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone, P., Neidhardt, E. M., Garcia, E., Galibert, L., van Kooten, C., & Banchereau, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1265 · Cited by 390
Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
Henkart, P. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90063-9 · Cited by 386
Sutton, V. R., Davis, J. E., Cancilla, M., Johnstone, R. W., Ruefli, A. A., Sedelies, K., Browne, K. A., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1403 · Cited by 386
CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance
Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R., & Ferguson, T. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80305-2 · Cited by 382
Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., & Nagata, S. (1995) · Nature Genetics · doi:10.1038/ng1195-294 · Cited by 374
NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing
Prager, I., Liesche, C., van Ooijen, H., Urlaub, D., Verron, Q., Sandström, N., Fasbender, F., Claus, M., Eils, R., Beaudouin, J., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181454 · Cited by 374
Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
Miwa, K., Asano, M., Horai, R., Iwakura, Y., Nagata, S., & Suda, T. (1998) · Nature Medicine · doi:10.1038/3276 · Cited by 373
Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice
Lacronique, V., Mignon, A., Fabre, M., Viollet, B., Rouquet, N., Molina, T., Porteu, A., Henrion, A., Bouscary, D., Varlet, P., et al. (1996) · Nature Medicine · doi:10.1038/nm0196-80 · Cited by 369
Fas-mediated cytotoxicity by freshly isolated natural killer cells.
Arase, H., Arase, N., & Saito, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1235 · Cited by 362
The role of CD95 and CD95 ligand in cancer
Peter, M. E., Hadji, A., Murmann, A. E., Brockway, S., Putzbach, W., Pattanayak, A., & Ceppi, P. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.3 · Cited by 357
Smyth, M. J., Krasovskis, E., Sutton, V. R., & Johnstone, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7024 · Cited by 356
Perforin: structure and function
Liu, C.-C., Walsh, C. M., & Young, J. D.-E. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80121-9 · Cited by 356
Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y., & Fontana, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117462 · Cited by 345
Fas and Fas Ligand: A Death Factor and Its Receptor
Nagata, S. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60672-0 · Cited by 338
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
Nitric Oxide Inhibits Fas-induced Apoptosis
Mannick, J. B., Miao, X. Q., & Stamler, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24125 · Cited by 315
Regulation of apoptosis in the immune system
Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., & Debatin, K.-M. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90102-3 · Cited by 308
Schulze-Osthoff, K., Krammer, P. H., & Dröge, W. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06780.x · Cited by 303
Ju, S. T., Cui, H., Panka, D. J., Ettinger, R., & Marshak-Rothstein, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4185 · Cited by 296
Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
Kojima, H., Shinohara, N., Hanaoka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90066-3 · Cited by 290
Albertine, K. H., Soulier, M. F., Wang, Z., Ishizaka, A., Hashimoto, S., Zimmerman, G. A., Matthay, M. A., & Ware, L. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64455-0 · Cited by 288
An early history of T cell-mediated cytotoxicity
Golstein, P., & Griffiths, G. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0009-3 · Cited by 284
Self-citationSensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity
Micheau, O., Solary, E., Hammann, A., Martin, F., & Dimanche-Boitrel, M.-T. (1997) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.783 · Cited by 281
Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.
Hanabuchi, S., Koyanagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kobayashi, Y., Yonehara, S., Yagita, H., & Okumura, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4930 · Cited by 280
Kägi, D., Seiler, P., Pavlovic, J., Ledermann, B., Bürki, K., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251209 · Cited by 278
Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway
Goillot, E., Raingeaud, J., Ranger, A., Tepper, R. I., Davis, R. J., Harlow, E., & Sanchez, I. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3302 · Cited by 263
Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
Maki, G., Klingemann, H.-G., Martinson, J. A., & Tam, Y. K. (2001) · Journal of Hematotherapy & Stem Cell Research · doi:10.1089/152581601750288975 · Cited by 262
Cytotoxicity Is Mandatory for CD8+ T Cell–mediated Contact Hypersensitivity
Kehren, J., Desvignes, C., Krasteva, M., Ducluzeau, M.-T., Assossou, O., Horand, F., Hahne, M., Kägi, D., Kaiserlian, D., & Nicolas, J.-F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.779 · Cited by 262
The role of FasL-induced apoptosis in immune privilege
Griffith, T. S., & Ferguson, T. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)81663-5 · Cited by 253
Rudi, J., Kuck, D., Strand, S., von Herbay, A., Mariani, S. M., Krammer, P. H., Galle, P. R., & Stremmel, W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2808 · Cited by 252
Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia
Maciejewski, J. P., Selleri, C., Sato, T., Anderson, S., & Young, N. S. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05277.x · Cited by 249
Apoptosis and functional fas antigen in rheumatoid arthritis synoviocytes
Nakajima, T., Aono, H., Hasunuma, T., Yamamoto, K., Shirai, T., Hirohata, K., & Nishioka, K. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380405 · Cited by 231
Yang, Y., Merćep, M., Ware, C. F., & Ashwell, J. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1673 · Cited by 223
Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
Gao, Y., Herndon, J. M., Zhang, H., Griffith, T. S., & Ferguson, T. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.887 · Cited by 217
Lowin, B., Beermann, F., Schmidt, A., & Tschopp, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11571 · Cited by 214
Anel, A., Buferne, M., Boyer, C., Schmitt‐Verhulst, A., & Golstein, P. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241032 · Cited by 197
Self-citationGrowth factors as survival factors: Regulation of apoptosis
Collins, M. K. L., Perkins, G. R., Rodriguez‐Tarduchy, G., Nieto, M. A., & López‐Rivas, A. (1994) · BioEssays · doi:10.1002/bies.950160210 · Cited by 193
Coxsackievirus B3-Induced Myocarditis
Gebhard, J. R., Perry, C. M., Harkins, S., Lane, T., Mena, I., Asensio, V. C., Campbell, I. L., & Whitton, J. L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65585-x · Cited by 181
Granzyme A-deficient mice retain potent cell-mediated cytotoxicity.
Ebnet, K., Hausmann, M., Lehmann-Grube, F., Müllbacher, A., Kopf, M., Lamers, M., & Simon, M. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00097.x · Cited by 179
Leite-de-Moraes, M. C., Hameg, A., Arnould, A., Machavoine, F., Koezuka, Y., Schneider, E., Herbelin, A., & Dy, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5871 · Cited by 177
Haanen, C., & Vermes, I. (1995) · Mediators of Inflammation · doi:10.1155/s0962935195000020 · Cited by 172
The unmet need in the elderly: Designing new influenza vaccines for older adults
McElhaney, J. E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.019 · Cited by 168
Apoptosis by a cytosolic extract from Fas-activated cells.
Enari, M., Hase, A., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00204.x · Cited by 162
Thymineless death in colon carcinoma cells is mediated via Fas signaling
Houghton, J. A., Harwood, F. G., & Tillman, D. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8144 · Cited by 158
Granzyme A Initiates an Alternative Pathway for Granule-Mediated Apoptosis
Shresta, S., Graubert, T. A., Thomas, D. A., Raptis, S. Z., & Ley, T. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80059-x · Cited by 158
Metadata
- Authors
- Rouvier, E., Luciani, M. F., & Golstein, P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-01-01
- Volume
- 177
- Issue
- 1
- Pages
- 195-200
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1989600187
- Cited by
- 787
- References
- 20
- FWCI
- 29.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.